Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Liquid Embolics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Liquid Embolics market segmented into
Isobutyl-2-Cyanoacrylate(IBCA)
Ethanol
Sodium Morrhuate
Bletilla Striata
Others
Based on the end-use, the global Liquid Embolics market classified into
Tumor and Brain Cancer
Brain Arteriovenous Malformations
Ischemic Stroke
Brain Aneurysm
Others
Based on geography, the global Liquid Embolics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Liquid Embolics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Liquid Embolics market segmented into
Isobutyl-2-Cyanoacrylate(IBCA)
Ethanol
Sodium Morrhuate
Bletilla Striata
Others
Based on the end-use, the global Liquid Embolics market classified into
Tumor and Brain Cancer
Brain Arteriovenous Malformations
Ischemic Stroke
Brain Aneurysm
Others
Based on geography, the global Liquid Embolics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL LIQUID EMBOLICS INDUSTRY
2.1 Summary about Liquid Embolics Industry
2.2 Liquid Embolics Market Trends
2.2.1 Liquid Embolics Production & Consumption Trends
2.2.2 Liquid Embolics Demand Structure Trends
2.3 Liquid Embolics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
4.2.2 Ethanol
4.2.3 Sodium Morrhuate
4.2.4 Bletilla Striata
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Tumor and Brain Cancer
4.3.2 Brain Arteriovenous Malformations
4.3.3 Ischemic Stroke
4.3.4 Brain Aneurysm
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
5.2.2 Ethanol
5.2.3 Sodium Morrhuate
5.2.4 Bletilla Striata
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Tumor and Brain Cancer
5.3.2 Brain Arteriovenous Malformations
5.3.3 Ischemic Stroke
5.3.4 Brain Aneurysm
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
6.2.2 Ethanol
6.2.3 Sodium Morrhuate
6.2.4 Bletilla Striata
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Tumor and Brain Cancer
6.3.2 Brain Arteriovenous Malformations
6.3.3 Ischemic Stroke
6.3.4 Brain Aneurysm
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
7.2.2 Ethanol
7.2.3 Sodium Morrhuate
7.2.4 Bletilla Striata
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Tumor and Brain Cancer
7.3.2 Brain Arteriovenous Malformations
7.3.3 Ischemic Stroke
7.3.4 Brain Aneurysm
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
8.2.2 Ethanol
8.2.3 Sodium Morrhuate
8.2.4 Bletilla Striata
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Tumor and Brain Cancer
8.3.2 Brain Arteriovenous Malformations
8.3.3 Ischemic Stroke
8.3.4 Brain Aneurysm
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
9.2.2 Ethanol
9.2.3 Sodium Morrhuate
9.2.4 Bletilla Striata
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Tumor and Brain Cancer
9.3.2 Brain Arteriovenous Malformations
9.3.3 Ischemic Stroke
9.3.4 Brain Aneurysm
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Medtronic
10.1.2 Boston Scientific
10.1.3 St. Jude Medical
10.1.4 Cyberonics
10.1.5 Codman & Shurtleff
10.1.6 Stryker
10.1.7 Integra LifeSciences
10.1.8 InoMed
10.1.9 Mizuho America
10.1.10 RauMedic
10.2 Liquid Embolics Sales Date of Major Players (2017-2020e)
10.2.1 Medtronic
10.2.2 Boston Scientific
10.2.3 St. Jude Medical
10.2.4 Cyberonics
10.2.5 Codman & Shurtleff
10.2.6 Stryker
10.2.7 Integra LifeSciences
10.2.8 InoMed
10.2.9 Mizuho America
10.2.10 RauMedic
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL LIQUID EMBOLICS INDUSTRY
2.1 Summary about Liquid Embolics Industry
2.2 Liquid Embolics Market Trends
2.2.1 Liquid Embolics Production & Consumption Trends
2.2.2 Liquid Embolics Demand Structure Trends
2.3 Liquid Embolics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
4.2.2 Ethanol
4.2.3 Sodium Morrhuate
4.2.4 Bletilla Striata
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Tumor and Brain Cancer
4.3.2 Brain Arteriovenous Malformations
4.3.3 Ischemic Stroke
4.3.4 Brain Aneurysm
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
5.2.2 Ethanol
5.2.3 Sodium Morrhuate
5.2.4 Bletilla Striata
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Tumor and Brain Cancer
5.3.2 Brain Arteriovenous Malformations
5.3.3 Ischemic Stroke
5.3.4 Brain Aneurysm
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
6.2.2 Ethanol
6.2.3 Sodium Morrhuate
6.2.4 Bletilla Striata
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Tumor and Brain Cancer
6.3.2 Brain Arteriovenous Malformations
6.3.3 Ischemic Stroke
6.3.4 Brain Aneurysm
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
7.2.2 Ethanol
7.2.3 Sodium Morrhuate
7.2.4 Bletilla Striata
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Tumor and Brain Cancer
7.3.2 Brain Arteriovenous Malformations
7.3.3 Ischemic Stroke
7.3.4 Brain Aneurysm
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
8.2.2 Ethanol
8.2.3 Sodium Morrhuate
8.2.4 Bletilla Striata
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Tumor and Brain Cancer
8.3.2 Brain Arteriovenous Malformations
8.3.3 Ischemic Stroke
8.3.4 Brain Aneurysm
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Isobutyl-2-Cyanoacrylate(IBCA)
9.2.2 Ethanol
9.2.3 Sodium Morrhuate
9.2.4 Bletilla Striata
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Tumor and Brain Cancer
9.3.2 Brain Arteriovenous Malformations
9.3.3 Ischemic Stroke
9.3.4 Brain Aneurysm
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Medtronic
10.1.2 Boston Scientific
10.1.3 St. Jude Medical
10.1.4 Cyberonics
10.1.5 Codman & Shurtleff
10.1.6 Stryker
10.1.7 Integra LifeSciences
10.1.8 InoMed
10.1.9 Mizuho America
10.1.10 RauMedic
10.2 Liquid Embolics Sales Date of Major Players (2017-2020e)
10.2.1 Medtronic
10.2.2 Boston Scientific
10.2.3 St. Jude Medical
10.2.4 Cyberonics
10.2.5 Codman & Shurtleff
10.2.6 Stryker
10.2.7 Integra LifeSciences
10.2.8 InoMed
10.2.9 Mizuho America
10.2.10 RauMedic
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
